Is Foundayo (orforglipron) compounded or FDA-approved?

The brand-name Foundayo tablet is FDA-approved — it went through the FDA's full review of safety, effectiveness, and manufacturing quality, per its DailyMed label. Compounded versions of orforglipron also exist, prepared by compounding pharmacies, but a compounded product is not itself an FDA-approved drug, even if it contains the same active ingredient.

What does 'compounded' mean for a GLP-1 medication?

A compounded medication is custom-prepared by a pharmacy, typically from bulk active ingredient, rather than manufactured and sold as an FDA-approved finished drug product. Compounded semaglutide and tirzepatide became widespread during shortages of the approved injectable products, and some compounding pharmacies now offer compounded orforglipron as well.

Is compounded semaglutide or tirzepatide the same as the FDA-approved drug?

Not necessarily. Some compounded products use salt forms or formulations of the active ingredient that differ from the FDA-approved version and haven't been proven safe and effective in the same clinical trials that supported approval of Ozempic, Wegovy, Mounjaro, or Zepbound. The FDA does not review or approve individual compounded formulations the way it does brand-name drugs.

Why do people choose compounded GLP-1s over an FDA-approved option?

Cost and access are the two most common reasons — compounded products have often been priced lower than brand-name self-pay pricing, and compounding filled gaps during supply shortages of the approved injectables. Availability and pricing for both compounded and brand-name options change often, so this isn't a fixed advantage either way.

Is compounded orforglipron cheaper than Foundayo?

This article can't give you a verified number for compounded orforglipron pricing, since compounding pharmacies set their own prices and don't publish a standardized rate the way Eli Lilly publishes Foundayo's self-pay pricing. If cost is your deciding factor, compare an actual quote from a compounding pharmacy against Foundayo's published self-pay and savings-card pricing rather than assuming either is cheaper.

Should I switch from a compounded GLP-1 to Foundayo, or vice versa?

That's a decision for you and your prescriber, who can weigh your treatment history, how you've responded so far, and the safety and quality tradeoffs of each option. This article doesn't recommend a switch either direction.

Compounded GLP-1s vs Orforglipron (Foundayo): What's the Difference?

Educational information, not medical advice. This guide is for general understanding of oral GLP-1 medicines. Always follow your prescriber's instructions and talk to a qualified clinician about your treatment.

Compounded orforglipron, semaglutide, and tirzepatide are custom-prepared by compounding pharmacies and are not themselves FDA-approved drug products, even when they contain the same active ingredient as an approved medication. Orforglipron, sold under the brand Foundayo, is FDA-approved — it went through the FDA’s full review of safety, effectiveness, and manufacturing quality. Compounded orforglipron also exists, and it carries the same distinction: same active ingredient, different regulatory status. Here’s what that difference actually means, without guessing at numbers no one has published.

What “compounded” means for a GLP-1 medication

A compounded drug is prepared by a pharmacy for an individual patient, typically starting from bulk active pharmaceutical ingredient, rather than being manufactured and sold as a finished, FDA-approved product. Compounding itself is legal and has a long history in medicine — it fills real gaps, like when a patient needs a dose strength or formulation that isn’t commercially available. Compounded weight loss drugs became a familiar term in the GLP-1 space specifically because of injectable shortages, not because compounding is unique to this drug class.

Compounded semaglutide and tirzepatide became widespread while the FDA-approved injectable versions (Ozempic, Wegovy, Mounjaro, Zepbound) were in shortage, since federal law allows compounding of a drug that’s officially listed as unavailable. Some compounding pharmacies now also offer compounded orforglipron. What compounding does not do is put the product through the FDA’s premarket review — the agency doesn’t evaluate or approve individual compounded formulations the way it approves a brand-name drug like Foundayo.

Is Foundayo FDA-approved or compounded?

Per its DailyMed label, Foundayo is an FDA-approved once-daily oral GLP-1 receptor agonist tablet, taken with or without food and no water restriction, approved for chronic weight management in adults with obesity or overweight with at least one weight-related condition. Every batch is manufactured to FDA-regulated quality standards, and the dose, formulation, and manufacturing process are fixed by the approval — you get the same product every time you fill the prescription.

That consistency is the core practical difference from a compounded product: a compounded formulation is prepared pharmacy-by-pharmacy, and its exact composition, purity, and dosing accuracy aren’t verified against the FDA’s approval standard.

Side-by-side comparison

	Foundayo (orforglipron, brand)	Compounded orforglipron / semaglutide / tirzepatide
FDA approval	FDA-approved finished drug product	Not FDA-approved as a finished product
Formulation	Fixed, per the approved label	Varies by compounding pharmacy; may use salt forms or ingredient sources not used in the approved drug
Manufacturing oversight	FDA-regulated manufacturing standards	Pharmacy compounding standards, not FDA premarket review
Dosing consistency	Standardized per approved label	Can vary batch to batch and pharmacy to pharmacy
Legal basis for availability	Standard prescription/dispensing	Traditionally tied to shortage status of the approved drug or individual patient need
Price	Published self-pay, insurance, and savings-card pricing	Set independently by each compounding pharmacy; no standardized published rate

Why does the compounded-vs-approved distinction matter for safety?

The active ingredients in GLP-1 medications — orforglipron, semaglutide, tirzepatide — have documented safety and side-effect profiles because they went through FDA-reviewed clinical trials in their approved forms. Per MedlinePlus and the Foundayo label, common side effects across this drug class are gastrointestinal: nausea, vomiting, diarrhea, and constipation, especially during dose increases.

A compounded product isn’t guaranteed to match that same safety picture. Some compounded semaglutide and tirzepatide formulations have used salt forms of the active ingredient, or other formulation choices, that differ from what was studied in the trials supporting Ozempic, Wegovy, Mounjaro, and Zepbound — meaning the safety and effectiveness data for the approved drug doesn’t automatically transfer to every compounded version. Dosing accuracy is also a real-world concern with compounded products dispensed in multidose vials, since it shifts more of the measurement burden onto the patient compared with a pre-set tablet or pen. If you’re on a compounded GLP-1 and considering switching to an FDA-approved option like Foundayo, Switching to Orforglipron covers what that transition involves — and it’s a conversation to have with your prescriber, not a decision to make on cost alone.

Where cost actually fits in

Price is a major reason people consider compounded GLP-1s, and it’s a legitimate factor — but it’s not one this article can put a number on for the compounded side, since compounding pharmacies set and change their own prices without a published standard rate. What’s actually published is Foundayo’s side: self-pay, insured, and Medicare Part D pricing, plus a manufacturer savings card for eligible patients, all covered in our Foundayo price guide. If cost is your deciding factor between a compounded product and Foundayo, get an actual current quote from the compounding pharmacy and compare it against Foundayo’s published pricing and your own insurance coverage — see Does Insurance Cover Orforglipron? — rather than assuming either option is automatically cheaper.

Bottom line

“Compounded” and “orforglipron” aren’t opposites — compounded orforglipron exists alongside compounded semaglutide and tirzepatide, and all of them sit on the other side of a real regulatory line from the FDA-approved brand-name product, Foundayo. The approved tablet comes with a fixed formulation, FDA-regulated manufacturing, and published pricing; a compounded version’s formulation, quality assurance, and price vary by pharmacy and aren’t reviewed against the same standard. Neither of those facts tells you which is right for you — that depends on your health history, access, and cost situation, and it’s worth talking through with a prescriber rather than deciding on price alone. For the fuller picture of what Foundayo involves day to day, see our Foundayo (Orforglipron) guide.